Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

NCT00456508 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
147
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shire